期刊文献+

Bcl-2和Cox-2在子宫内膜癌中的表达 被引量:2

Expressions of Cox-2 and Bcl-2 in endometrial carcinoma tissue
下载PDF
导出
摘要 目的:研究Bcl-2和Cox-2在子宫内膜癌中的表达,并对其临床意义做初步探讨。方法:采用免疫组织化学SP法检测25例正常子宫内膜,15例不典型增生子宫内膜,56例子宫内膜癌Bcl-2和Cox-2的分布及表达。结果:(1)Cox-2在正常子宫内膜、子宫内膜不典型增生、子宫内膜癌中的阳性表达率逐渐增强,阳性率分别为12%,40%及69.64%,差异高度显著(P<0.05),Cox-2的表达强度与组织分化程度、肌层浸润深度正相关(P<0.05)。(2)Bcl-2在增生期子宫内膜、子宫内膜不典型增生、子宫内膜腺癌中的表达强度逐渐降低,阳性率分别为96%,73.33%,44.64%,差异显著(P<0.05)。内膜腺癌中,Bcl-2的表达强度与组织分化程度、肌层浸润深度、淋巴结转移负相关(均P<0.05)。(3)内膜腺癌中,Bcl-2与Cox-2的表达明显相关性(P<0.05)。结论:Cox-2及Bcl-2可能与子宫内膜癌的早期形成有一定关系,共同参与子宫内膜腺癌的发生、发展。 Objective:To investigate the expression of Cox-2 and Bcl-2 genes and clinical significance in endometrial adenocarcinoma.Methods:A cross-sectional study was conducted in 96 women in the following categories:(1)normal endometrium(n=25),(2) atypical hyperplastic endometrium(n=15),and(3)endometrial carcinoma(n=56).The expression of Cox-2 and Bcl-2 was investigated by SP immunohi-immunohistochemical assay.Results:(1) The expression of Cox-2 increased progressively from normal and atypical hyperplastic endometrium to carcinoma(12%,40% and69.64%,respectively) with a significant difference(P<0.05).The expression of Cox-2 in endometrial adenocarcinoma had a great relevancy with the histologicalgrade and myometrial invasion.(2)The expressioof Bcl-2 decreased gradually from normal and atypical hyperplasticendometrium to carcinoma with positivity of 96%, 73.33% and 44.64%,respectively,with a significant difference(P<0.05).The expression of Bcl-2 in endometrial adenocarcinoma was reversely related with histologicalgrade,lymph node metastasis and myometrial invasion(P<0.05;P<0.05;P<0.05).(3) A noticeable relation was found between Bcl-2 gene expression and Cox-2 gene expression.Conclusion:The decreased expression of Bcl2 and Cox-2 might be one of early events in the occurrence of endometrial carcinoma.The above two factors were highly expressed in endometrial adenocarcinoma and closely related with the clinical-pathological parameters.
出处 《黑龙江医药科学》 2009年第5期24-25,共2页 Heilongjiang Medicine and Pharmacy
关键词 COX-2 BCL-2 子宫内膜腺癌 免疫组织化学 细胞凋亡 Cox-2 Bcl-2 endometriala enocarcinoma immunohisto chemicalmethod apoptosis
  • 相关文献

参考文献6

  • 1Appleby SB,Ristimaki A,Neilson K,et al.Structure of the human cyclo-oxygenase-2 gene[].Biochemical Journal.1994
  • 2Morita I,Schindler M,Regier M K,et al.Different intracellular locations for prostagladin endoperoxide H synthase-1 and-2[].Journal of Biological Chemistry.1995
  • 3Dannenberg A J,Altorki N K,Boyle J O,et al.Cyclooxygenase-2: a pharmacological target fox the prevention of cancer[].Lancet OncologyThe.2001
  • 4Tsujimoto Y,Finger LR,Yunis J,et al.Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation[].Science.1984
  • 5Watanabe H,Kanzaki H,Narukawa S,et al.Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis[].American Journal of Obstetrics and Gynecology.1997
  • 6Lu,Q-L,Poulsom,R,Wong,L,Hanby,AM.BCL-2 expression in adult and embryonic non-haematopoietic tissues[].Journal of Paleopathology.1993

同被引文献19

  • 1赵丽萍,陆晓媛.Annexin A2、Bcl-2在宫颈癌中的表达及意义[J].徐州医学院学报,2010,30(8):507-510. 被引量:5
  • 2李巧稚,拉莱.苏祖克,林晨,阿仙姑力.哈斯木.凋亡相关基因Bcl-2、Bag-1在宫颈上皮病变中的表达及意义[J].新疆医科大学学报,2007,30(6):589-591. 被引量:4
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin,2011,61:69 -90.
  • 4Burkly LC, Michaelson JS, Hahm K, et al. TWEAKing tissue re - modeling by a multifunetional cytokine: role of TWEAK/Fnl4 path -way in health and disease[ J]. Cytokine, 2007,40 (1) :1 -16.
  • 5Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a newsecreted ligand in the tumor necrosis factor family that weakly induces apopto- sis[J]. J Biol Chem,1997,272(51 ) :32401 -32410.
  • 6Wiley SR, Cassiano L, Lofton T, et al. A novel TNF receptorfamily member binds TWEAK and is implicated in angiogenesis[ J]. Immu- nity,2001,15(5) :837-846.
  • 7Lynch CN, Wang YC, Lund JK, et al. TWEAK induces an - giogene- sis and proliferation of endothelial cells [ J ]. J BiolChem, 1999,274 ( 13 ) :8455 - 8459.
  • 8Kim SH, Kang YJ, Kim WJ, et 8.1. TWEAK can induce pro - inflam -matory eytokines and matrix metalloproteinase -9 in macrophages [J]. Circ J, 2004,68(4) :396 -399.
  • 9Kamijo S, Nakajima A, Kamata K, et al. Involvement of TWEAK/ Fnl4 interaction in the synovial inflammation of RA [ J]. Rheumatol -ogy (Oxford), 2008,47(4) :442-450.
  • 10Donohue PJ, Richards CM, Brown SA, et al. TWEAK is an endo- the - lial cell growth and chemotactic factor that also potentiates FGF- 2and VEGF- A mitogenic activity[ J]. Arterioscler Thromb Vasc Bio[ ,2003,23 (4) :594 - 600.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部